Proteinase K Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-5465 Status : Upcoming

Description

Global Proteinase K Market: Overview

Proteinase K is a substrate from serine protease. Proteinase K is from stable S8 serine alkaline protease family groups containing one free cys and two disulfide bridges. It is used to digest proteins and eliminate contamination from the preparation of nucleic acid. These further inactivate nucleases that degrade DNA or RNA during the purification and isolation process. It determines the membrane's enzyme localization. It also digests the protein from the sample of brain tissue.

Global Proteinase K Market: Growth Factors

The proliferation of proteinase enzymes in the extraction of RNA and DNA for in-vitro examination and diagnosis is fueling the global proteinase K market growth. Proteinase K is used in the in-vitro examination due to its ability to remove the endotoxins which bind to lysozyme, ribonuclease A, and other cationic proteins. It also helps to isolate the mitochondria out of the hepatic cells and analyze enzyme localization over the membrane. It is used while antibody labeling in the treatment of paraffin-embedded segments of tissue.

All of these factors contribute to the growth of the global proteinase K market. Proteinase K assists in accurate detection of COVID-19 and thus, is expected to drive the market growth globally over the forecast period.

There is significant traction to use proteinase K via RT-qPCR because PCR is known to be the standard technology for COVID-19 detection.

Major explorations in the usage of proteinase K by healthcare professionals to unleash its potential to enhance the accuracy and quality of test results are likely to boost the market growth over the forecast period.

Global Proteinase K Market: Segmentation

The global proteinase K market can be segmented into therapeutic area, form, and region.

By therapeutic area, the market can be classified into neurology, autoimmune disease, nephrology, cardiology, oncology, diabetes, and infectious diseases.

Of these, the infectious disease holds the largest share in the global proteinase K market. The broad spectrum application of proteinase K in the examination and diagnosis of many infectious diseases is the major factor that fuels the proteinase K market globally. Proteinase K helps in the successful treatment of many infectious diseases. It assists in efficient DNA isolation and incubation from Hepatitis B virus with high yielding results.

Many studies say the DNA yield results by proteinase K are more efficient and reliable than the standard methods without the use of proteinase K.

The neurology segment is likely to grow with a significant increase in CAGR. The growth is attributed to the increased utilization of proteinase K in the diagnosis of prion diseases. The surge in adoption of this enzyme as an alternative to trypsin for efficient cross-linking studies is expected to drive the segment growth.

By form, the market can be segmented into powder and liquid.

The powdered form permits stock-based solutions as per the protocol requirements. Moreover, this powdered form holds a long shelf-life when compared to others.

Global Proteinase K Market: Regional analysis

North America holds the largest share in the global proteinase K market. The surge in the cases of cancer leads to growth in polymerase chain relation and next-generation sequence applications. These factors anticipate market growth in the coming years.

Asia Pacific is expected to witness a high growth rate over the forecast period due to the high cases of the coupled disorder.

China is expected to foresee high death rates due to cancer. This propels the regional market growth due to the increased utilization of proteinase K in the cancer biopsy specimen.

Constantly increasing COVID-19 cases are expected to boost the Asian market constantly due to the use of enzymes in COVID-19 detection.

Global Proteinase K Market: Competitive Players

Some of the significant leaders in the global proteinase K market are American Laboratories, Affymetrix, BBI Solutions, Dyadic International, Amicogen, Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., Amano Enzyme Inc., F. Hoffmann-La Roche Ltd., Codexis, Inc., and Merck KGaA.

Global Proteinase K Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social